Home -
Products -
Chromatin/Epigenetic -
Epigenetic Reader Domain -
SMARCA-BD ligand 1 for Protac dihydrochloride
SMARCA-BD ligand 1 for Protac dihydrochloride
CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride( —— )
Catalog No. M33234 CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 84 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 317 | In Stock |
|
| 100MG | 434 | In Stock |
|
| 200MG | 602 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSMARCA-BD ligand 1 for Protac dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
-
DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2369053-68-7
-
Formula Weight344.24
-
Molecular FormulaC14H19Cl2N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2.7 mg/mL (7.84 mM; Ultrasonic (<60°C)
-
SMILESCl.Cl.Nc1nnc(cc1N1CCNCC1)-c1ccccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.?
molnova catalog
related products
-
Curcumin
Curcumin is a natural phenolic compound with impressive antioxidant properties. Curcumin is recently proved to exert its chemopreventive effects partly through the activation of nuclear factor (erythroid-2 related) factor 2 (Nrf2).
-
FHD-286
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
CPI-203
CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
Cart
sales@molnova.com